DocGo Inc. (DCGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -83.33%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.09, delivering a surprise of -800%.Over the last four quarters, the company has surpassed ...

DocGo (DCGO) Q2 2025 Earnings Call August 07, 2025 05:00 PM ET Speaker0Good afternoon, ladies and gentlemen, and welcome to the DocGo Second Quarter Earnings Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. At any time during this call, you require immediate assistance. Please press 0 for the operator.This call is being recorded on Thursday, 08/07/2025. I would now like to turn the conference over to Mike Cole, VP, I ...

Exhibit 99.1 DocGo Announces Second Quarter 2025 Results Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK, NY, August 7 , 2025 – DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39618 DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-2515483 | | --- | --- ...

Summary of Dotco Inc. (DocGo) Conference Call Company Overview - **Company Name**: Dotco Inc. (Ticker: DCGO) - **Industry**: Mobile healthcare and medical transportation - **Core Mission**: Deliver healthcare at any address, improving health outcomes by meeting patients where they are [3][9] Key Points and Arguments 1. **Service Model**: Dotco provides tech-driven mobile care, focusing on bringing healthcare to patients in their homes, offices, or community settings [6][10] 2. **Market Opportunity**: The total addressable market (TAM) for home healthcare is estimated at $265 billion, with a significant shift towards non-traditional providers [33] 3. **Patient Engagement**: The company has a high patient net promoter score of 87, indicating strong satisfaction among patients [11] 4. **Cost Savings**: Dotco has saved partners over $265 million through emergency department diversion programs, reducing unnecessary hospital visits [12] 5. **Growth Metrics**: In the last year, Dotco provided care across 31 states and the UK, with over 1.5 million patient interactions and 8.8 million miles traveled [12][13] 6. **Financial Performance**: The company reported $96 million in revenue for Q1, with an adjusted gross margin of 32.1% [20][21] 7. **Cash Position**: Dotco has over $100 million in cash on the balance sheet, up from approximately $58.9 million the previous year [20][22] 8. **Strategic Partnerships**: The company has signed contracts with major health plans, increasing the number of patients assigned to their services from 500,000 to over 900,000 [23] 9. **Chronic Disease Focus**: The CDC estimates that 90% of the $4.5 trillion in annual healthcare spending is for individuals with chronic diseases, highlighting the need for Dotco's services [24][25] 10. **Technology Integration**: Dotco's proprietary technology platform enhances efficiency in patient care delivery and integrates with hospital systems for better patient management [42][43] Additional Important Insights - **Emergency Response**: Dotco played a significant role during the COVID-19 pandemic and the migrant crisis, providing testing, vaccinations, and medical care [16][17] - **Vertical Integration**: The company has a vertically integrated model, combining technology, staffing, and clinical services to enhance patient care [47] - **Future Outlook**: Dotco is optimistic about the growth potential in mobile health and medical transportation, even as they wind down emergency services related to COVID-19 [44][45] - **Healthcare System Efficiency**: The company aims to reduce hospital readmissions and improve bed management through efficient medical transportation services [30][42] This summary encapsulates the key points discussed during the Dotco Inc. conference call, highlighting the company's innovative approach to healthcare delivery and its significant market potential.

High quality, highly accessible healthcare For all © 2 0 2 5 A l l R i g h t s R e s e r ve d – D oc Go Disclaimer This presentation is being delivered solely for informational purposes. No representation or warranty, express or implied, is made by DocGo, its affiliates, or any of their respective directors, officers, shareholders, members, partners or representatives as to the accuracy or completeness of any information in this presentation. Except where otherwise indicated, this presentation speaks as of ...

Financial Data and Key Metrics Changes - The company celebrated its ten-year anniversary and reported facilitating care across its ten millionth patient interaction, indicating significant growth in scale and impact [12][13] - The company achieved record levels in medical transportation trip volume in Q1 2025 and anticipates continued growth with new customers [16][17] Business Line Data and Key Metrics Changes - In the Care Gap closure program, total assigned lives increased to over 900,000, up from 700,000 just a quarter ago [20] - Visit volumes in the Care Gap program scaled from 2,500 visits in Q4 2023 to over 4,400 in Q4 2024, with projections of more than 11,500 visits in Q4 2025, representing a fourfold increase in two years [20] Market Data and Key Metrics Changes - The company provided services across 31 states in the US and the UK, with its proprietary tech platform calculating over 15 million estimated arrival times for customers [14] - The company’s care gap closure program achieved a net promoter score of 86, significantly higher than the healthcare industry benchmark of 58 [15] Company Strategy and Development Direction - The company aims to build a long-term sustainable business by focusing on its core medical transportation and mobile health services, which are expected to grow in 2025 and 2026 [16][26] - The strategic decision to enhance operations and technology is intended to support the growing needs of the customer base and ensure predictable long-term growth [15][26] Management's Comments on Operating Environment and Future Outlook - Management highlighted the increasing demand for services due to chronic diseases and the need for proactive care, which aligns with the company's offerings [22][23] - The company is positioned to address significant challenges in the US healthcare system, including high costs and clinician burnout, by providing accessible care [23][27] Other Important Information - The company acquired PTI Health, a mobile lab collection and phlebotomy business, which is expected to complete 125,000 blood draws in 2025 and over 200,000 in 2026 [21] - The company is actively managing SG&A expenses and believes it has the financial strength to fund its next growth phase [26] Q&A Session Summary Question: What are the key milestones achieved by the company recently? - The company recently facilitated care for its ten millionth patient and achieved record trip volumes in medical transportation [12][16] Question: How does the company plan to address the challenges in the healthcare system? - The company aims to provide proactive care to manage chronic diseases and reduce costs, thereby benefiting the overall healthcare ecosystem [23][27]

Summary of DocGo (DCGO) FY Conference Call - June 09, 2025 Company Overview - **Company**: DocGo (DCGO) - **Industry**: Mobile healthcare and medical transportation - **Core Business**: Provides medical transportation and mobile healthcare services, focusing on bringing care to patients where needed and transporting patients to care locations [4][5] Key Points and Arguments Business Model and Growth - **Medical Transportation**: The company has a robust medical transportation platform, which includes a tech platform that calculates estimated times of arrival (ETAs) for medical transport, having calculated 15 million ETAs last year [5][6] - **Crisis Response**: The company played a significant role during the COVID-19 pandemic and the migrant crisis in New York City, which helped establish its reputation and capabilities [6][7] - **Patient Care**: Over the past ten years, DocGo has cared for 10 million patients, focusing on expanding capabilities in home healthcare and medical transportation [8] - **Revenue Guidance**: The medical transit business is projected to generate $315 million at the midpoint, with growth driven by partnerships with large hospital systems [9][10] Growth Drivers - **Hospital Partnerships**: The company partners with major hospital systems, utilizing its tech platform to manage patient flow and transportation, which has led to organic growth [10][12] - **Market Expansion**: DocGo is expanding geographically, with recent expansions into Chattanooga and Dallas-Fort Worth, and is targeting a growth trajectory of 20% by increasing transit numbers from 575,000 to 700,000 [16][18] - **Service Expansion**: There is potential to deepen relationships with existing hospital systems by offering additional services beyond medical transportation, such as cardiac monitoring and transitional care management [15][19] Market Dynamics - **Fragmented Industry**: The medical transportation industry is highly fragmented, and DocGo's investment in technology allows it to capture market share by providing a more efficient service compared to traditional methods [21][22] - **Predictability in Operations**: The company’s model provides predictability for hospital systems, allowing them to manage patient flow more effectively, which is a significant value proposition [29][27] Financial Performance and Guidance - **Accounts Receivable**: The company has made progress in collecting outstanding receivables, reducing the balance from $150 million to $100 million [67] - **Municipal Revenue**: The company has removed municipal revenue from guidance due to unpredictability but expects to report it separately as it comes in [70][71] Payer-Facing Business - **Care Gap Services**: The company is expanding its payer-facing business by addressing care gaps for patients who are chronically ill and have difficulty accessing care [35][36] - **Patient Engagement**: DocGo has successfully engaged with a growing list of patients, now totaling 900,000, to close care gaps, which is a significant growth opportunity [39][43] - **Revenue Model**: Currently, the company operates on a fee-for-service model, with plans to transition to value-based payments as it establishes a primary care practice [46][44] Operational Efficiency - **Labor Model**: The company employs a unique model where licensed practical nurses (LPNs) are dispatched to patients' homes, directed by centralized healthcare providers, optimizing resource use [61][62] - **Cost Management**: DocGo is rationalizing its SG&A expenses while maintaining capabilities for future growth, particularly in the payer and provider verticals [79][80] Additional Important Insights - **Patient Management**: The company emphasizes the importance of patient bed management for hospitals, which can save significant costs associated with building new capacity [28][29] - **Long-Term Relationships**: DocGo aims to fill the void for patients without primary care providers, establishing long-term relationships where necessary [56][57] - **Future Outlook**: The company is optimistic about its growth trajectory, with plans to expand services and geographic reach while maintaining a focus on operational efficiency and patient care [54][55]

Company Performance - DocGo Inc. reported a quarterly loss of $0.09 per share, missing the Zacks Consensus Estimate of a loss of $0.01, and compared to earnings of $0.09 per share a year ago, representing an earnings surprise of -800% [1] - Motion Acquisition posted revenues of $96.03 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 0.90%, and down from year-ago revenues of $192.09 million [2] - Over the last four quarters, Motion Acquisition has surpassed consensus EPS estimates just once and has not been able to beat consensus revenue estimates [2] Stock Performance - Motion Acquisition shares have lost approximately 43.4% since the beginning of the year, while the S&P 500 has declined by -4.3% [3] - The current consensus EPS estimate for the coming quarter is $0.01 on $92.8 million in revenues, and $0.07 on $401.83 million in revenues for the current fiscal year [7] Industry Outlook - The Medical Services industry is currently in the top 22% of over 250 Zacks industries, indicating a favorable outlook as the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] - The estimate revisions trend for Motion Acquisition is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $96 million, down from $192.1 million in Q1 2024, primarily due to the decline in the government vertical, especially in migrant-related projects [18] - The company recorded a net loss of $11.1 million in Q1 2025 compared to a net income of $10.6 million in Q1 2024, reflecting the drop in revenues [19] - Adjusted EBITDA for Q1 2025 was a loss of $3.9 million, down from adjusted EBITDA of $24.1 million in Q1 2024 [20] - SG&A as a percentage of total revenues was 46.7% in Q1 2025, compared to 26.8% in Q1 2024, indicating a significant increase due to the decline in migrant revenues [23] Business Line Data and Key Metrics Changes - Mobile health revenue for Q1 2025 was $45.2 million, down from $143.9 million in Q1 2024, driven by the anticipated wind down of migrant revenues [19] - Medical transportation services revenue increased to $50.8 million in Q1 2025 from $48.2 million in Q1 2024, supported by growth in several markets [19] - The medical transportation business is expected to generate $225 million in revenue for 2025, while the payer and provider business is projected to generate $50 million [17] Market Data and Key Metrics Changes - The company has seen growth in medical transportation services in markets including Delaware, Tennessee, Pennsylvania, New Jersey, Wisconsin, Upstate New York, and the UK [19] - The payer and provider vertical has exceeded 900,000 assigned lives, up from 700,000 just a quarter ago, indicating strong demand [10] Company Strategy and Development Direction - The company has removed its government population health vertical from its 2025 guidance due to ongoing policy changes and budget cuts, leading to substantial uncertainty [5][7] - The focus is on building the company around innovative solutions for payers, providers, and health systems, particularly in mobile health and medical transportation [8] - The company is undertaking cost-cutting measures while investing in growing segments, aiming for positive adjusted EBITDA in 2026 [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth trajectory of the medical transportation and payer/provider verticals despite the challenges in the government sector [8][17] - The anticipated adjusted EBITDA loss for 2025 is primarily due to elevated SG&A levels during the transition period [15] - Management highlighted the importance of patient satisfaction and the positive impact of their services on healthcare outcomes, which is expected to drive future growth [40][70] Other Important Information - The company plans to report any significant non-migrant municipal work as upside revenue in future quarters [17] - The balance sheet remains healthy, with expectations of positive cash flow from operations despite projected losses [16][25] - The company has initiated a stock buyback program, repurchasing nearly 2 million shares for approximately $5.8 million [26] Q&A Session Summary Question: What is the expected government revenue for the remainder of the year? - Management clarified that government population health revenues have been removed from guidance, and any new deployments will be reported separately as upside [30][31] Question: How is the payer business performing? - The payer business is experiencing healthy demand, with plans focused on reducing medical loss ratios and improving quality metrics [38][40] Question: What caused the revenue miss in Q1? - The revenue miss was attributed to the government vertical, with delays in contract launches and RFP responses impacting expected revenues [46][51] Question: What is the margin profile of the migrant-related revenue? - The margin for the migrant program was about 34%, consistent with previous quarters, while the non-migrant mobile health segment had higher margins [75] Question: Are there risks from tariffs on medical equipment? - Management indicated that tariffs could impact the cost of maintaining the fleet and procuring new vehicles, but they are well-positioned to manage these costs [77][78]